Omeros Corp
Pharmaceutical Preparations · Seattle, WA, United States
- PrincipalsDavid J. BorgesVP, Finance & CAOGregory A MD DemopulosChairman, CEO & President
- CompanyOmeros CorpSeattle, WA, United States
- Phone line+1 (206) 676-5000General business
Omeros Corp is an SEC-registered Nasdaq-listed company (ticker OMER) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 2
Chief executive
Gregory A MD DemopulosChairman, CEO & President
Everyone else on file (1)
David J. BorgesVP, Finance & CAO
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Gregory A MD Demopulos — Chairman, CEO & President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David J. Borges — VP, Finance & CAO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pl. VIIMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityPl. VIIBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityPl. VIIAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityPl. VIIAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityPl. VIICannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityPl. VIIInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityPl. VIIChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityPl. VIIXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capability